Starbucks denies that its decision to stop selling Chicken, Maple Butter, and Egg Sandwich on June 26, a mere five days after it had been announced as a new permanent menu item, was due to FDA recall or salmonella or listeria contamination.
A Starbucks spokesperson said that the Chicken, Maple Butter, and Egg Sandwich was given a voluntary stop sell and discard order by the company because it didn't live up to the company's high standards for quality.
The quality issue that was identified by Starbucks was simply about taste or based on another issue and would not lead to food-borne illness and any reports linking the stop sale to illness are inaccurate.
The spokesperson added that Starbucks is devoted to providing high-quality products, and anytime a concern about a product or its quality is expressed, we always proceed with extreme caution.


Asian Currencies Steady as Fed Delivers Hawkish Rate Cut; Aussie and Rupee Under Pressure
Office design isn’t keeping up with post-COVID work styles - here’s what workers really want
BOJ Expected to Deliver December Rate Hike as Economists See Borrowing Costs Rising Through 2025
Can your cat recognise you by scent? New study shows it’s likely
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
Ireland Limits Planned Trade Ban on Israeli Settlements to Goods Only
Asian Currencies Hold Steady as Indian Rupee Slides to Record Low on Fed Outlook
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
Indonesia–U.S. Tariff Talks Near Completion as Both Sides Push for Year-End Deal
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs
Parents abused by their children often suffer in silence – specialist therapy is helping them find a voice
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
What’s the difference between baking powder and baking soda? It’s subtle, but significant
The ghost of Robodebt – Federal Court rules billions of dollars in welfare debts must be recalculated
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles
Coca-Cola’s Costa Coffee Sale Faces Uncertainty as Talks With TDR Capital Hit Snag 



